Business Context and Reporting Period
This Form 8-K is filed by Elevai Labs Inc. (trading symbol: ELAB) on September 4, 2024. The registrant is a Delaware corporation listed on The Nasdaq Capital Market. The filing addresses critical compliance failures regarding Nasdaq listing standards that threaten the continued listing of the company's common stock.
Key Financial Metrics and Liquidity
- Stockholders' Equity: Approximately $2.6 million as of June 30, 2024.
- Minimum Equity Requirement: $2.5 million (Nasdaq Listing Rule 5550(b)(1)).
- Minimum Bid Price Requirement: $1.00 per share (Nasdaq Listing Rule 5550(a)(2)).
- Historical Burn Rate: Cited by Nasdaq as a factor in determining non-compliance with equity rules, though specific dollar amounts are not provided in this filing.
- Capital Raising Capacity: The filing notes that delisting could impair the company's ability to raise capital.
Material Changes and Compliance Status
The company has failed to regain compliance with two distinct Nasdaq listing rules:
- Bid Price Rule: The stock failed to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days starting March 6, 2024. The 180-day compliance period expired on September 3, 2024. The company did not qualify for an extension because it lacked $5 million in stockholders' equity.
- Stockholders' Equity Rule: Although reported equity was $2.6 million (above the $2.5 million threshold) as of June 30, 2024, Nasdaq determined the company failed to regain compliance due to the "small margin" of compliance and historical burn rate. A compliance plan submitted in August 2024 was deemed insufficient to demonstrate the ability to maintain compliance over the next 9-12 months.
Outlook, Risks, and Management Commentary
Management intends to appeal Nasdaq's determination to the Nasdaq Hearings Panel for both the Bid Price and Stockholders' Equity violations. The company plans to submit a written request, pay the required fee, and present a compliance plan. Filing this appeal will stay the delisting process pending the Panel's decision. The stock will continue to trade on Nasdaq under the symbol "ELAB" during this period.
Risks and Contingencies:
- There is no assurance the appeal will be successful or that the company will regain compliance.
- If delisted, the stock may become more difficult to buy or sell, and accurate quotations may be unavailable.
- Delisting could result in a material decline in share price.
- The company's ability to raise future capital may be impaired.
Investor Verification Checklist
- Verify the current status of the appeal with the Nasdaq Hearings Panel.
- Review the specific details of the compliance plan submitted to Nasdaq to assess feasibility.
- Monitor the company's cash burn rate and liquidity position in subsequent filings (e.g., Form 10-Q).
- Check for any announcements regarding a reverse stock split or capital raise intended to address the bid price and equity deficiencies.
- Confirm whether the stock continues to trade on Nasdaq or moves to the OTC market if the appeal fails.